·ù¸¶Æ¼½º°üÀý¿° Ä¡·á ȯ°æÀ» °³¼±Çϱâ À§ÇØ ¾ÕÀå
·ù¸¶Æ¼½º°üÀý¿°ÀÇ Áø´Ü ¸¶Ä¿¸¦ ¹ß±¼ÇÏ°í °Á÷¼º ôÃß¿°ÀÇ Á¤·®Àû °ñ ¼Õ»ó Æò°¡ ¹× ÁöÇ¥¸¦ °³¹ßÇÏ´Â µî ·ù¸¶Æ¼½º°üÀý¿° Ä¡·á ȯ°æÀ» °³¼±Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ´Ù.
Á¦ ¸ñ | Serial changes in the coronary artery: Isolated immunoglobulin G4-related coronary arteritis | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2023.10 | ¹ßÇ¥Áö | EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING |
Á¦ ¸ñ | Quantitative prediction of radiographic progression in patients with axial spondyloarthritis using neural network model in a real-world setting | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2023.04 | ¹ßÇ¥Áö | ARTHRITIS RESEARCH & THERAPY |
Á¦ ¸ñ | Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case Report | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022.11 | ¹ßÇ¥Áö | INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS |
Á¦ ¸ñ | Denosumab-Related Osteonecrosis of the Jaw May Not Be a Subject of Teriparatide Treatment | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022.10 | ¹ßÇ¥Áö | JOURNAL OF BONE AND MINERAL RESEARCH |
Á¦ ¸ñ | Use of Disease-modifying Antirheumatic Drugs After Cancer Diagnosis in Rheumatoid Arthritis Patients | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022.07 | ¹ßÇ¥Áö | JOURNAL OF RHEUMATIC DISEASES(´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö) |
Á¦ ¸ñ | Clinical Implications of Shared Epitope and Anti-citrullinated Peptide Antibody in Patients With Rheumatoid Arthritis | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022.07 | ¹ßÇ¥Áö | JOURNAL OF RHEUMATIC DISEASES(´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö) |
Á¦ ¸ñ | Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2022.07 | ¹ßÇ¥Áö | LANCET |
°¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿øÀº °æ±â³²ºÎÁö¿ª ÃÖÃÊÀÇ Àǰú´ëÇк´¿øÀ¸·Î 1967³â °³¿øÇß´Ù. ¼ººó¼¾Æ®º´¿øÀº ¡®ÀüÀÎ Ä¡·á ½ÇÇö¡¯À» ¸ñÇ¥·Î °í³µµ ÁßÁõ Áúȯ Áß½ÉÀÇ Áø·á ¿ª·® °È¸¦ ÅëÇÑ ÀÇ·áÀÇ ÁúÀû ¼öÁØ Çâ»ó°ú ȯÀÚ Áß½ÉÀÇ ÄèÀûÇÏ°í Æí¾ÈÇÑ Áø·á ȯ°æ ¹× È¿À²ÀûÀÎ Áø·á ½Ã½ºÅÛ ±¸ÃàÀ» À§ÇØ ´Ù°¢µµÀÇ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ´Ù. ¾Ïº´¿ø ¹× ½É³úÇ÷°üº´¿ø, ·Îº¿¼ö¼ú¼¾ÅÍ, ÇÏÀ̺긮µåÇ÷°ü¼¾ÅÍ µî ÃÖ÷´Ü ÀÇ·á½Ã¼³°ú Àåºñ, ½Ç·Â ÀÖ´Â ÀÇ·áÁøµéÀ» °®Ãß°í, °í³µµ ÁßÁõÁúȯÀ» Áß½ÉÀ¸·Î Áø·á ¿ª·® ÁýÁßÇϰí ÀÖ´Ù.
°æ±âµµ ¼ö¿ø½Ã ÆÈ´Þ±¸ Áߺδë·Î 93